摘要 |
Compounds of formula (I) and salts and solvates are provided wherein R<SUP>2</SUP> is selected from phenyl substituted with n R<SUP>1</SUP> groups, and pyridyl substituted with n R<SUP>1</SUP> groups; n = 0, 1 or 2; each R<SUP>1</SUP> is independently selected from the group consisting of halo, C<SUB>1-4</SUB>alkyl, C<SUB>1-4</SUB>alkoxy, haloC<SUB>1-4</SUB>alkyl, haloC<SUB>1-4</SUB>alkoxy and cyano; R<SUP>3</SUP> is selected from hydrogen and C<SUB>1-2</SUB> alkyl; R<SUP>4</SUP> is selected from the group consisting of ethyl, n- propyl, i-propyl, n-butyl, i-butyl and t-butyl; or R<SUP>3</SUP> and R<SUP>4</SUP> together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocyclic ring optionally substituted with one or more groups X; each X is independently selected from the group consisting of C<SUB>1-4</SUB>alkyl, and haloC<SUB>1-4</SUB>alkyl; R<SUP>12</SUP> is selected from the group consisting of hydrogen, fluoro, chloro, bromo, methyl and methylthio; R<SUP>13</SUP> is selected from hydrogen, chloro and trifluoromethyl; R<SUP>14</SUP> is selected from hydrogen, trifluoromethyl and chloro; R<SUP>15</SUP> is selected from hydrogen, chloro and trifluoromethyl; R<SUP>16</SUP> is selected from hydrogen, methyl, fluoro and chloro; R<SUP>12</SUP>, R<SUP>13</SUP>, R<SUP>14</SUP>, R<SUP>15</SUP> and R<SUP>16</SUP> not all simultaneously being hydrogen. Processes for the preparation and uses of the compounds as medicaments for treating disorders such as psychoses, dementia or attention deficit disorder are also disclosed. |
申请人 |
GLAXO GROUP LIMITED;COULTON, STEVEN;GILPIN, MARTIN;PORTER, RODERICK, ALAN |
发明人 |
COULTON, STEVEN;GILPIN, MARTIN;PORTER, RODERICK, ALAN |